Evolus to Participate in the 10th Annual SVB Leerink Global Healthcare Conference
- Wall Street slips off record highs, Tesla drops after fatal crash
- IBM (IBM) Tops Q1 EPS by 14c, Revenue Beats
- UK to Intervene in Nvidia's (NVDA) ARM Deal, Analyst Says Although Intervention 'Carries Significant Weight,' NVDA is Still a Buy
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
NEWPORT BEACH, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of management will be participating in the 10th Annual SVB Leerink Global Healthcare Conference.
|Event:||10th Annual SVB Leerink Global Healthcare Conference|
|Format:||Fireside Chat & 1x1 Meetings|
|Date:||Wednesday, February 24, 2021|
|Time:||1:00pm – 1:30pm ET|
|Location:||Evolus Live Fireside Chat|
An audio webcast of Evolus’ fireside chat will be available on the investor relations section of Evolus’ website at investors.evolus.com. Replays of the webcasts will be available for 90 days after the date of the presentation.
About Evolus, Inc.
Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products. In 2019, the U.S. Food and Drug Administration approved Jeuveau® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure™ technology. Jeuveau® is powered by Evolus' unique technology platform and is designed to transform the aesthetic market by eliminating the friction points existing for customers today. Visit us at: www.evolus.com.
Jeuveau® is a registered trademark of Evolus, Inc.
Hi-Pure™ is a trademark of Daewoong Pharmaceutical Co, Ltd.
Evolus, Inc. Contacts:
Investor Contact:Ashwin Agarwal, Evolus, Inc.Vice President, Finance, Investor Relations & TreasuryTel: +1-949-284-4559Email: IR@Evolus.com
Media Contact:Crystal Muilenburg, Evolus, Inc.Vice President, Corporate Communications & Public RelationsTel: +1-949-284-4506Email: email@example.com
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wintrust Financial Corporation Reports Record First Quarter 2021 Net Income of $153.1 million
- Purpose Investments Inc. Announces April Distributions
- Now is Not the Time: IBD patients call on Queen’s Park to delay the non-medical switch of their essential medication that will jeopardize their health during the COVID-19 pandemic